Braveheart Bio, Inc. (BRVE)
NGM · Healthcare · Biotechnology
$21.48
+2.09%
Closing price as of 2026-10-22 · Source: TEK2day Finance
1-Year Price History
-27.9% over period
Key Metrics
Quarterly Financials
| Metric | 2025-03-31 | 2025-06-30 | 2026-03-31 | 2026-06-30 |
| Revenue | | 0.00 | | 0.00 |
| Operating Income | | (27K) | | (15.9M) |
| Net Income | | (381K) | | (15.0M) |
| Diluted EPS | $-0.00 | $-0.01 | $-0.33 | $-0.25 |
Annual Financials
| Metric | 2025-12-31 |
| Diluted EPS | $-5.32 |
Want live quotes, estimates, SEC filings, and CEO analytics for BRVE?
The free TEK2day terminal runs in your browser — type /BRVE to get started.
Open BRVE in the Terminal →